Tuberculosis (TB) screening frequently involves skin tests or blood analyses performed at occupational health clinics like Concentra. These assessments evaluate an individual’s exposure to and potential infection with the bacteria that cause TB. A skin test typically involves a small injection under the skin, while blood tests analyze immune responses. Results generally categorize individuals as having latent TB infection (exposure without active disease), active TB disease (requiring immediate treatment), or no indication of infection.
Early detection through such screening is critical for controlling the spread of tuberculosis. Identifying latent infections allows for preventative treatment, reducing the risk of developing active TB disease. For employers, ensuring a TB-free workforce safeguards employee health and minimizes potential disruptions. Historically, TB control has been a significant public health challenge, and modern screening methods represent a vital tool in managing and ultimately eradicating the disease.
